1 / 3

Wearable injectors market

The last of couple of years have seen an ever-increasing interest and demand in wearable injectors. This in turn has boosted the growth of the Wearable Injectors Market considerably. It is projected to grow at a whopping 15.2% CAGR over the forecast period (2018-2023).

SiaWGR
Download Presentation

Wearable injectors market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Market Research Future Wearable Injectors Global Market 2019 - Competitive Landscape, Strategies, Share, Trends, Segmentation, Growth Forecast 2023 Wearable Injectors Market -Insights The last of couple of years have seen an ever-increasing interest and demand in wearable injectors. This in turn has boosted the growth of the Wearable Injectors Market considerably. It is projected to grow at a whopping 15.2% CAGR over the forecast period (2018-2023). Global Wearable Injectors Research Report: By Type (On-Body, Off-Body, Hand Held), by Usage (Disposable, Semi-Reusable), by Mechanism of Injection (Spring Based, Others), by Therapeutic Area (Oncology, Diabetes, Others), by End-User– Forecast Till 2023 Wearable Injectors represent a novel class of injectable drug delivery system. It can be worn on the patient’s body as it delivers into the body the prescribed drug. As opposed to an insulin pump, a wearable injector is designed for just a single use. Post pushing the injection, the patient can peel it off and discard it. A Wearable Injector is largely used for delivering biologic drugs which a patient cannot administer through the standard handheld device. Most of these devices are used for treating autoimmune diseases such as Crohn’s disease/IBD, rheumatoid arthritis, psoriasis and for insulin delivery. Get Free Sample @ https://www.marketresearchfuture.com/sample_request/6491 A wearable injector is convenient, user-friendly and will reduce the requirement for numerous painful injections. Also known as patch pumps or bolus injectors, the wearable injectors are utilized for subcutaneously administering insulin as well as other drugs which need extended delivery period and large dose volumes. There are many factors that is fueling the growth of the wearable injectors market. The different market trends and factors in this market according to an analysis performed by Market Research Future (MRFR) include upsurge in diabetes and cancer cases, use of cutting-edge technological products, rise in the incidence of needlestick injuries, growing need for 24/7 monitoring, shift to injectables that can be self-administered and prevalence of diseases that are lifestyle-associated such as hypertension and diabetes. On the contrary, lack of skilled labor is likely to hamper the wearable injectors market growth. Wearable Injectors Market -Key Players Some of the key players in the Global Wearable Injectors Market are West Pharmaceutical Services, Inc., Valeritas, Inc., Eli Lilly and Company, YPSOMED, Amgen Inc., Becton, Dickinson and Company (BD), CeQur SA, SteadyMed Therapeutics, Inc., BioSpace, Enable Injections, and Sensile Medical AG.

  2. Market Research Future Wearable Injectors Market -Regional Analysis Based on region, the Wearable Injectors Market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will dominate the market due to advanced technologies for administering drugs to treat chronic diseases such as diabetes and the existence of superior healthcare infrastructure. Europe holds the second position owing to the developing medical devices industry in the UK, Germany and France coupled with the increasing opportunities for market players. In the APAC region, the wearable injectors market is projected in being the fastest developing over the forecast period due to good government initiatives taken for the medical device industry. In the Middle East and Africa, the market is expected to have a minimum share. The growth of the wearable injectors market in this region is due to increasing R&D activities here. Wearable Injectors Market -Segmentation In the Market Research Future (MRFR) report, the Wearable Injectors Market has been segmented based on type, usage, mechanism of action, therapeutic area and end-user. Based on type, the market can be segmented into hand-held wearable injectors, off-body wearable injectors and on-body wearable injectors. Of these, the on-body wearable injectors will have the maximum market share. Based on usage, the wearable injectors market is segmented into semi-reusable and disposable. Based on the mechanism of action, it is segmented into collapsible reservoir, pressurized gas, expanding battery, rotary pump, motor driven, and spring based. Based on therapeutic area, it is segmented into diabetes, autoimmune diseases, cardiovascular diseases, infectious diseases and oncology. Of these, the autoimmune diseases are anticipated in being the fastest growing during the predicted years. Based on end-user, the wearable injectors market is segmented into ambulatory surgery centers, homecare, clinics, hospitals and others. Of these, homecare is predicted to have the maximum market share. Industry/Innovation/Related News: February 08, 2019 West Pharmaceutical Services, Inc. (the US), one of the world’s largest manufacturers and sellers of containment and delivery systems for injectable drugs and healthcare products announced its plans of partnering with Swissfillon AG (Switzerland), a provider of aseptic fill and finish services to pharmaceutical and biotechnology companies for Clinical Filling of SmartDose® Drug Delivery Platform.

  3. Market Research Future The partnership that is intended to lead to a non-exclusive global collaboration to provide fill-finish capabilities to customers using West’s proprietary SmartDose drug delivery platform for complex molecules. Through the collaboration, it is anticipated that West will be able to deliver an integrated solution with filled Daikyo Crystal Zenith® cartridges for the SmartDose wearable injector. January 29, 2019 scPharmaceuticals Inc. (the US), a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products announced its partnership with West Pharmaceutical Services, Inc. (the US), one of the world’s largest manufacturers and sellers of containment and delivery systems for injectable drugs and healthcare products to incorporate West’s SmartDose Drug Delivery System with the its (SC’s) lead drug FUROSCIX (furosemide), in development for treating edema in heart failure patients. Browse Complete 100 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/wearable-injectors-market-6491 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India +1 646 845 9312 Email: salesteam@marketresearchfuture.com

More Related